Breaking News Instant updates and real-time market news.

SGYP

Synergy Pharmaceuticals

08:06
10/17/16
10/17
08:06
10/17/16
08:06

Synergy: Plecanatide associated with low adverse events in long-term study

Synergy Pharmaceuticals presented new long-term safety data of plecanatide, its investigational, orally-administered compound currently being evaluated by the U.S. FDA for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation. These data, which were presented at the American College of Gastroenterology annual scientific meeting, showed that plecanatide was associated with low adverse events and low discontinuation rates in patients with CIC who received plecanatide once-daily for up to 72 weeks. In this long-term study, which evaluated 2,370 patients, the most common adverse events in both dose groups were diarrhea and urinary tract infection. The remainder of adverse events occurred in less than 2% of patients treated with plecanatide. Adverse events leading to discontinuation occurred in 5.3% of patients treated with plecanatide, with discontinuation due to diarrhea occurring in 3.1% of patients. In addition, this study asked patients about level of treatment satisfaction and desire to continue treatment. The median score for treatment satisfaction was 4.0 and for continuation of treatment was 4.0. The Prescription Drug User Fee Act target action date for plecanatide in CIC is January 29, 2017. In addition, Synergy has already completed patient recruitment for the two double-blind, placebo-controlled Phase 3 clinical trials with plecanatide in IBS-C and remains on-track to report top-line data from both trials in the fourth quarter of this year. Pending approval in the CIC indication, Synergy plans to file a New Drug Application Supplement with Clinical Data for plecanatide in IBS-C in the first quarter of 2017 and expects a 10-month review period from submission.

  • 29

    Jan

SGYP Synergy Pharmaceuticals

12/18/15
SBSH
12/18/15
DOWNGRADE
Target $7
SBSH
Neutral
Synergy Pharmaceuticals downgraded to Neutral from Buy at Citi
Citi analyst Liav Abraham downgraded Synergy Pharmaceuticals (SGYP) to Neutral saying the commercial potential of plecanatide will be "significantly lower" than that of Linzess. He also views the probability of a takeout of the company as less likely. The analyst cut his price target for the shares to $7 from $12. Abraham calls Synergy and Insmed (INSM) his least favored small-cap Specialty Pharma names for 2016.
12/18/15
12/18/15
DOWNGRADE

On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Aixtron (AIXG) downgraded to Equal Weight from Overweight at Morgan Stanley... ArcelorMittal (MT) downgraded to Sector Perform from Outperform at RBC Capital... Biodel (BIOD) downgraded to Market Perform from Outperform at William Blair... Boeing (BA) downgraded to Market Perform from Outperform at Wells Fargo... Bristow Group (BRS) downgraded to Market Perform from Outperform at William Blair... Charles Schwab (SCHW) downgraded to Neutral from Overweight at Piper Jaffray... Denbury Resources (DNR) downgraded at Stifel... EMC Insurance (EMCI) downgraded to Hold from Buy at Sandler O'Neill... Forum Energy (FET) downgraded to Market Perform from Outperform at William Blair... Fossil (FOSL) downgraded to Sell from Neutral at Goldman... GasLog Partners (GLOP) downgraded to Underweight from Neutral at JPMorgan... Herman Miller (MLHR) downgraded to Market Perform from Outperform at Raymond James... Hub Group (HUBG) downgraded to Neutral from Outperform at Baird... Investors Real Estate (IRET) downgraded to Hold from Buy at Wunderlich... Kindred Healthcare (KND) downgraded to Market Perform from Outperform at Avondale... Knight Transportation (KNX) downgraded to Neutral from Buy at Citi... LaSalle Hotel (LHO) downgraded to Underweight from Equal Weight at Barclays... National Oilwell (NOV) downgraded to Market Perform from Outperform at William Blair... Patriot National (PN) downgraded to Market Perform from Outperform at William Blair... Plains All American (PAA) downgraded to Neutral from Accumulate at Seaport Global... Plains GP Holdings (PAGP) downgraded to Neutral from Accumulate at Seaport Global... RLJ Lodging Trust (RLJ) downgraded to Underweight from Equal Weight at Barclays... Sandvik AB (SDVKY) downgraded to Underperform from Hold at Jefferies... Seadrill Partners (SDLP) downgraded to Neutral from Buy at Seaport Global... Synergy Pharmaceuticals (SGYP) downgraded to Neutral from Buy at Citi... Texas Instruments (TXN) downgraded to Market Perform from Outperform at Bernstein... Tim Participacoes (TSU) downgraded to Sell from Neutral at Goldman... Ultra Petroleum (UPL) downgraded on commmodity outlook, debt at Stifel.
09/14/16
09/14/16
NO CHANGE

Citi calls Synergy Pharmaceuticals a potential target for Takeda
09/14/16
SBSH
09/14/16
NO CHANGE
Target $4
SBSH
Neutral
Citi views Synergy Pharmaceuticals as potential target for Takeda
Citi analyst Liav Abraham calls Synergy Pharmaceuticals (SGYP) the most likely potential target for Takeda Pharmaceutical (TKPYY) among her coverage universe. The Financial Times earlier today reported that Takeda is ready to spend as much as $15B in acquisitions to expand its business in the United States. Abraham has a Neutral rating on Synergy with a $4 price target. The analyst sees Synergy as a potential target given the "extensive resources" needed to commercialize its lead asset, plecanatide, as well as Takdea's presence in the irritable bowel syndrome/chronic idiopathic constipation space. Shares of Synergy are up 6% to $5.18 in early trading.

TODAY'S FREE FLY STORIES

CSCO

Cisco

$34.26

-0.06 (-0.17%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Cisco to host service provider tech talk »

Cisco SVP Kanouff hosts a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 03

    Mar

04:55
02/28/17
02/28
04:55
02/28/17
04:55
General news
Breaking General news story  »

Kansas City Federal…

AQMS

Aqua Metals

$16.38

-0.33 (-1.97%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Aqua Metals management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 01

    Mar

  • 02

    Mar

WSTC

West Corp.

$24.37

0.01 (0.04%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
West Corp. to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

EFX

Equifax

$130.81

1.43 (1.11%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Equifax to hold a webcast »

Equifax Senior Vice…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 01

    Mar

  • 02

    Mar

  • 02

    Mar

DLA

Delta Apparel

$18.03

0.37 (2.10%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Delta Apparel management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

LPCN

Lipocine

$4.01

0.15 (3.89%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Lipocine management to meet with Roth Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 21

    Mar

04:55
02/28/17
02/28
04:55
02/28/17
04:55
General news
Breaking General news story  »

4-Week Bill Auction to be…

04:55
02/28/17
02/28
04:55
02/28/17
04:55
General news
Breaking General news story  »

St. Louis Federal Reserve…

HCKT

Hackett Group

$20.13

0.12 (0.60%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Hackett Group management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 01

    Mar

VRTU

Virtusa

$30.49

2.14 (7.55%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Virtusa management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 07

    Mar

  • 16

    Mar

  • 21

    Mar

  • 22

    Mar

  • 27

    Mar

  • 28

    Mar

SRC

Spirit Realty

$11.07

0.08 (0.73%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Spirit Realty management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

TGT

Target

$66.91

0.4 (0.60%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Target to hold a financial community meeting »

Management holds 2017…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 19

    Mar

ALXN

Alexion

$132.20

0.66 (0.50%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Alexion management to meet with Leerink »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

LOPE

Grand Canyon

$61.27

0.58 (0.96%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Grand Canyon management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Leerink analysts hold an analyst/industry conference call »

In conjunction with the…

04:55
02/28/17
02/28
04:55
02/28/17
04:55
General news
Real GDP to be reported at 08:30 »

Real GDP will be reported…

04:55
02/28/17
02/28
04:55
02/28/17
04:55
General news
Consumer Confidence to be reported at 10:00 »

February Consumer…

ANTM

Anthem

$164.91

1.08 (0.66%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Anthem management to meet with Wolfe Research »

Wolfe Healthcare Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

AGU

Agrium

$98.96

-0.41 (-0.41%)

, AAL

American Airlines

$46.32

0.04 (0.09%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
BMO Capital to hold a conference »

26th Global Metals &…

AGU

Agrium

$98.96

-0.41 (-0.41%)

AAL

American Airlines

$46.32

0.04 (0.09%)

ABX

Barrick Gold

$18.91

-0.63 (-3.22%)

AEM

Agnico Eagle

$42.46

-2.76 (-6.10%)

ANTO

Use ANFGY

BLT

Blount

CCO

Clear Channel Outdoor

$4.75

0.1 (2.15%)

FCX

Freeport McMoRan

$13.27

0.02 (0.15%)

FNV

Franco-Nevada

$64.05

-1.84 (-2.79%)

GEM

Pepsi-Gemex ADR

$29.26

-0.13 (-0.44%)

GG

Goldcorp

$16.02

-0.55 (-3.32%)

HBM

Hudbay Minerals

$7.90

-0.1 (-1.25%)

IVN

trades under IVPAF

NUE

Nucor

$62.64

1.78 (2.92%)

PDL

Project Design Labs

POT

Potash

$17.83

-0.04 (-0.22%)

RIO

Rio Tinto

$41.83

0.14 (0.34%)

SLW

Silver Wheaton

$19.66

-1.49 (-7.04%)

STLD

Steel Dynamics

$36.70

1.11 (3.12%)

TECK

Teck Resources

$20.06

-0.66 (-3.19%)

NEM

Newmont Mining

$33.97

-2.11 (-5.85%)

MOS

Mosaic

$31.27

0.12 (0.39%)

AA

Alcoa

$34.78

0.3 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 05

    Mar

  • 22

    Mar

  • 23

    Mar

  • 02

    May

WMAR

West Marine

$9.38

-0.57 (-5.73%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
West Marine management to meet with B. Riley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

JPM

JPMorgan

$90.43

0.1 (0.11%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
JPMorgan to host investor day with a conference call hook-up »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 03

    Mar

  • 14

    Jul

  • 12

    Oct

  • 13

    Apr

  • 13

    Jul

  • 12

    Oct

04:55
02/28/17
02/28
04:55
02/28/17
04:55
General news
International Trade in Goods Balance to be reported at 08:30 »

January International…

04:55
02/28/17
02/28
04:55
02/28/17
04:55
General news
GDP price index to be reported at 08:30 »

GDP price index will be…

04:55
02/28/17
02/28
04:55
02/28/17
04:55
General news
Chicago PMI Business Barometer Index to be reported at 09:45 »

February Chicago PMI…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.